145 related articles for article (PubMed ID: 32656636)
1. Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma.
Chilmi S; Nakahata S; Fauzi YR; Ichikawa T; Tani C; Suwanruengsri M; Yamaguchi R; Matsuura T; Kurosawa G; Morishita K
Int J Hematol; 2020 Oct; 112(4):496-503. PubMed ID: 32656636
[TBL] [Abstract][Full Text] [Related]
2. Cell adhesion molecule-1 (CADM1) expressed on adult T-cell leukemia/lymphoma cells is not involved in the interaction with macrophages.
Komohara Y; Ma C; Yano H; Pan C; Horlad H; Saito Y; Ohnishi K; Fujiwara Y; Okuno Y; Nosaka K; Shimosaki S; Morishita K; Matsuoka M; Wakayama T; Takeya M
J Clin Exp Hematop; 2017 Jul; 57(1):15-20. PubMed ID: 28420814
[TBL] [Abstract][Full Text] [Related]
3. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
[TBL] [Abstract][Full Text] [Related]
4. Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-κB.
Sarkar B; Nishikata I; Nakahata S; Ichikawa T; Shiraga T; Saha HR; Fujii M; Tanaka Y; Shimoda K; Morishita K
Sci Rep; 2019 Mar; 9(1):3491. PubMed ID: 30837480
[TBL] [Abstract][Full Text] [Related]
5. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma.
Nakahata S; Morishita K
J Clin Exp Hematop; 2012; 52(1):17-22. PubMed ID: 22706526
[TBL] [Abstract][Full Text] [Related]
6. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma.
Nakahata S; Syahrul C; Nakatake A; Sakamoto K; Yoshihama M; Nishikata I; Ukai Y; Matsuura T; Kameda T; Shide K; Kubuki Y; Hidaka T; Kitanaka A; Ito A; Takemoto S; Nakano N; Saito M; Iwanaga M; Sagara Y; Mochida K; Amano M; Maeda K; Sueoka E; Okayama A; Utsunomiya A; Shimoda K; Watanabe T; Morishita K
Haematologica; 2021 Feb; 106(2):532-542. PubMed ID: 32054656
[TBL] [Abstract][Full Text] [Related]
8. Trans-homophilic interaction of CADM1 promotes organ infiltration of T-cell lymphoma by adhesion to vascular endothelium.
Kasai Y; Gan SP; Funaki T; Ohashi-Kumagai Y; Tominaga M; Shiu SJ; Suzuki D; Matsubara D; Sakamoto T; Sakurai-Yageta M; Ito T; Murakami Y
Cancer Sci; 2022 May; 113(5):1669-1678. PubMed ID: 35213073
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma.
Nakahata S; Saito Y; Marutsuka K; Hidaka T; Maeda K; Hatakeyama K; Shiraga T; Goto A; Takamatsu N; Asada Y; Utsunomiya A; Okayama A; Kubuki Y; Shimoda K; Ukai Y; Kurosawa G; Morishita K
Leukemia; 2012 Jun; 26(6):1238-46. PubMed ID: 22289924
[TBL] [Abstract][Full Text] [Related]
10. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.
Ishii T; Ishida T; Utsunomiya A; Inagaki A; Yano H; Komatsu H; Iida S; Imada K; Uchiyama T; Akinaga S; Shitara K; Ueda R
Clin Cancer Res; 2010 Mar; 16(5):1520-31. PubMed ID: 20160057
[TBL] [Abstract][Full Text] [Related]
11. The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma.
Yamaguchi M; Morizane S; Hamada T; Miyake T; Sugaya M; Iwata H; Fujii K; Haramoto-Shiratsuki R; Nakagawa Y; Miura M; Ohshima K; Morishita K; Takahashi T; Imada M; Okada K; Uehara J; Sowa-Osako J; Iwatsuki K
J Dermatol; 2019 Nov; 46(11):967-977. PubMed ID: 31515833
[TBL] [Abstract][Full Text] [Related]
12. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
13. Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.
Chiba M; Shimono J; Suto K; Ishio T; Endo T; Goto H; Hasegawa H; Maeda M; Teshima T; Yang Y; Nakagawa M
Blood; 2024 Apr; 143(14):1379-1390. PubMed ID: 38142436
[TBL] [Abstract][Full Text] [Related]
14. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.
Ishida T; Iida S; Akatsuka Y; Ishii T; Miyazaki M; Komatsu H; Inagaki H; Okada N; Fujita T; Shitara K; Akinaga S; Takahashi T; Utsunomiya A; Ueda R
Clin Cancer Res; 2004 Nov; 10(22):7529-39. PubMed ID: 15569983
[TBL] [Abstract][Full Text] [Related]
15. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
[TBL] [Abstract][Full Text] [Related]
16. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
Ceesay MM; Matutes E; Taylor GP; Fields P; Cavenagh J; Simpson S; Ho A; Devereux S; Mufti GJ; Pagliuca A
Leuk Res; 2012 Jul; 36(7):857-61. PubMed ID: 22209076
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Ishio T; Kumar S; Shimono J; Daenthanasanmak A; Dubois S; Lin Y; Bryant B; Petrus MN; Bachy E; Huang DW; Yang Y; Green PL; Hasegawa H; Maeda M; Goto H; Endo T; Yokota T; Hatanaka KC; Hatanaka Y; Tanaka S; Matsuno Y; Yang Y; Hashino S; Teshima T; Waldmann TA; Staudt LM; Nakagawa M
Blood; 2022 Mar; 139(10):1541-1556. PubMed ID: 34818414
[TBL] [Abstract][Full Text] [Related]
18. A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells.
Lee JH; Kim JW; Yang HR; Song SW; Lee SJ; Jeon Y; Ju A; Lee N; Kim MG; Kim M; Hwang K; Yoon JH; Shim H; Lee S
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805896
[TBL] [Abstract][Full Text] [Related]
19. Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer.
Li H; Gao J; Zhang S
Front Cell Dev Biol; 2021; 9():714298. PubMed ID: 34395444
[TBL] [Abstract][Full Text] [Related]
20. The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies.
Sawada Y; Mashima E; Saito-Sasaki N; Nakamura M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
